4
Changes in Ownership
Wave Life Sciences, Inc. Filed Acc 0000950170-25-110287
Director sold 21,000 shares at $9.25 ($194,250)
- Director acquired 21,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Tan Aik Na · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +21,000 | $9.13 | $191,730 | 61,388 | D |
| 2025-08-15 | Sale : show line 2 in the form 10b5-1 | −21,000 | $9.25 | $194,250 | 40,388 | D |
| Open-market sales · 21,000 sh · avg $9.25 · $194,250 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-08-15 | Exercise or conversion : show line 3 in the form 10b5-1 Share Option (right to buy) | −21,000 | 0 | D |
Loading xslF345X05/ownership.xml…